State Street SPDR S&P Pharmaceuticals ETF (XPH)
XMEX 
Summary
XPH Chart
Which Healthcare ETF Is the Better Buy: State Street's Pharma XPH or Simplify's Mission-Driven PINK?
State Street SPDR S&P Pharmaceuticals ETF offers a lower expense ratio but has a lower dividend yield than Simplify Health Care ETF. Simplify Health Care ETF has shown significantly lower maximum drawdowns than the SPDR fund over the last five years.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
XPH: Healthcare Sector Dashboard For October
Pharmaceuticals/biotechnology are currently overvalued by 14% versus 11-year averages, while healthcare equipment appears undervalued despite recent value score deterioration. State Street SPDR S&P Pharmaceuticals ETF offers diversified pharma exposure with low company-specific risk due to its modified equal-weight methodology. XPH is best suited for tactical allocation or swing trading, not as a compelling long-term holding, given its historical risk-return profile and sector dynamics.
State Street SPDR S&P Pharmaceuticals ETF (XPH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has State Street SPDR S&P Pharmaceuticals ETF ever had a stock split?
State Street SPDR S&P Pharmaceuticals ETF Profile
| XMEX Exchange | US Country |
Overview
The fund is designed to mirror the performance of the S&P Pharmaceuticals Select Industry Index. This Index is a subset of the S&P Total Market Index (S&P TMI) and specifically highlights the pharmaceuticals sector. To achieve its investment aim, the fund utilizes a sampling strategy. This means it doesn't necessarily invest in all the securities that the Index is composed of but selects a representative sample. By policy, the fund dedicates a substantial portion—if not all—of its assets towards investing in securities that make up the Index, committing at least 80% of its total assets to such investments.
Products and Services
- S&P Pharmaceuticals Select Industry Index Tracking:
The primary offering of the fund is its investment vehicle that aims to follow the performance of the S&P Pharmaceuticals Select Industry Index. This Index reflects the pharmaceuticals segment within the wider S&P Total Market Index. Through this product, investors gain exposure to a broad range of pharmaceutical companies without having to invest individually in each. It's a way to diversify one’s investment in the pharmaceutical sector efficiently and with reduced risk compared to picking single stocks.
- Sampling Strategy Investment Approach:
Unlike funds that practice full replication of their benchmark indices, this fund employs a sampling strategy. This method involves selecting a sample of securities that, in aggregate, are intended to approximate the full Index in terms of key risk factors, performance metrics, and other characteristics. This approach allows the fund to potentially reduce transaction costs and improve liquidity, making it an efficient way to achieve similar performance as the Index it tracks.
Contact Information
